Bilhartz DL - Search Results

1

Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer.

Smith MR, Kabbinavar F, Saad F, Hussain A, Gittelman MC, Bilhartz DL, Wynne C, Murray R, Zinner NR, Schulman C, Linnartz R, Zheng M, Goessl C, Hei YJ, Small EJ, Cook R, Higano CS. Smith MR, et al. Among authors: bilhartz dl. J Clin Oncol. 2005 May 1;23(13):2918-25. doi: 10.1200/JCO.2005.01.529. J Clin Oncol. 2005. PMID: 15860850 Clinical Trial.

2

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer.

Kantoff PW, Schuetz TJ, Blumenstein BA, Glode LM, Bilhartz DL, Wyand M, Manson K, Panicali DL, Laus R, Schlom J, Dahut WL, Arlen PM, Gulley JL, Godfrey WR. Kantoff PW, et al. Among authors: bilhartz dl. J Clin Oncol. 2010 Mar 1;28(7):1099-105. doi: 10.1200/JCO.2009.25.0597. Epub 2010 Jan 25. J Clin Oncol. 2010. PMID: 20100959 Free PMC article. Clinical Trial.

3

Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases.

Polascik TJ, Given RW, Metzger C, Julian SR, Vestal JC, Karlin GS, Barkley CS, Bilhartz DL, McWhorter LT, Lacerna LV. Polascik TJ, et al. Among authors: bilhartz dl. Urology. 2005 Nov;66(5):1054-9. doi: 10.1016/j.urology.2005.05.035. Urology. 2005. PMID: 16286123 Clinical Trial.

4

Prostate specific antigen in hormonally treated stage D2 prostate cancer: is it always an accurate indicator of disease status?

Leo ME, Bilhartz DL, Bergstralh EJ, Oesterling JE. Leo ME, et al. Among authors: bilhartz dl. J Urol. 1991 Apr;145(4):802-6. doi: 10.1016/s0022-5347(17)38456-2. J Urol. 1991. PMID: 1706440

5

Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP.

Young CY, Montgomery BT, Andrews PE, Qui SD, Bilhartz DL, Tindall DJ. Young CY, et al. Among authors: bilhartz dl. Cancer Res. 1991 Jul 15;51(14):3748-52. Cancer Res. 1991. PMID: 1712248

6

Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP.

Montgomery BT, Young CY, Bilhartz DL, Andrews PE, Prescott JL, Thompson NF, Tindall DJ. Montgomery BT, et al. Among authors: bilhartz dl. Prostate. 1992;21(1):63-73. doi: 10.1002/pros.2990210107. Prostate. 1992. PMID: 1379363

7

Flow cytometric DNA ploidy pattern for predicting metastasis of clinical stage I nonseminomatous germ cell testicular tumors.

Austenfeld MS, Bilhartz DL, Nativ O, Farrow GM, Lieber MM. Austenfeld MS, et al. Among authors: bilhartz dl. Urology. 1993 Apr;41(4):379-83. doi: 10.1016/0090-4295(93)90604-9. Urology. 1993. PMID: 8385834 Review.

8

In situ hybridization of prostate-specific antigen mRNA in human prostate.

Qiu SD, Young CY, Bilhartz DL, Prescott JL, Farrow GM, He WW, Tindall DJ. Qiu SD, et al. Among authors: bilhartz dl. J Urol. 1990 Dec;144(6):1550-6. doi: 10.1016/s0022-5347(17)39797-5. J Urol. 1990. PMID: 1700164

9

Prostate-specific antigen and prostatic acid phosphatase: biomolecular and physiologic characteristics.

Bilhartz DL, Tindall DJ, Oesterling JE. Bilhartz DL, et al. Urology. 1991 Aug;38(2):95-102. doi: 10.1016/s0090-4295(05)80066-4. Urology. 1991. PMID: 1715106 Review.

10

Pitfalls of "bench surgery" and autotransplantation for renal cell carcinoma.

Stormont TJ, Bilhartz DL, Zincke H. Stormont TJ, et al. Among authors: bilhartz dl. Mayo Clin Proc. 1992 Jul;67(7):621-8. doi: 10.1016/s0025-6196(12)60715-0. Mayo Clin Proc. 1992. PMID: 1434894

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters